ALKERMES | Zysk Brutto

Pre Tax Profit Zmiana Data
AbbVie USD 5.99B 243M 2023-12
Acadia Pharmaceuticals USD 39.7M 91.85M 2023-12
Acorda Therapeutics USD -20876000 7.82M 2021-09
Amgen USD 3.03B 153M 2023-12
Biogen USD 801.7M 231.6M 2023-06
BioMarin Pharmaceutical USD 33.33M 8.34M 2023-12
Bluebird Bio USD -71731000 1.26M 2023-09
Bristol-Myers Squibb USD 4.07B 613M 2023-12
Eli Lilly USD 2.59B 2.27B 2023-12
Gilead Sciences USD 2.59B 586M 2023-12
Heron Therapeutics USD -25008000 17.05M 2023-09
Intra Cellular Therapies USD -28131000 3.92M 2023-12
Ionis Pharmaceuticals USD -3000000 138M 2023-12
Marinus Pharmaceuticals USD -32972000 500K 2023-09
Merck USD -473000000 6.86B 2023-12
Minerva Neurosciences USD -7821000 1.63M 2023-09
Nektar Therapeutics USD -45898000 5.27M 2023-09
Neurocrine Biosciences USD 198.2M 82.6M 2023-12
Otsuka Holdings JPY 74.38B 14.78B 2023-09
Pfizer USD -1250000000 5.38B 2023-09
Regeneron Pharmaceuticals USD 1.4B 54.4M 2023-12
Revance Therapeutics USD -140876000 73.56M 2023-09
Vertex Pharmaceuticals USD 1.31B 9.6M 2023-12



ALKERMES Zysk Brutto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2024.